NasdaqCM - Delayed Quote USD

Accelerate Diagnostics, Inc. (AXDX)

1.1200

+0.0100

+(0.90%)

At close: 4:00:00 PM EST

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections, today announced certain preliminary, unaudited results for the quarter and year ended December 31, 2024.

PR Newswire 6 days ago

AXDX
+0.90%
Q3 2024 Accelerate Diagnostics Inc Earnings Call

Q3 2024 Accelerate Diagnostics Inc Earnings Call

Thomson Reuters StreetEvents 2 months ago

AXDX
+0.90%
Accelerate Diagnostics Inc (AXDX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

Despite a net loss, Accelerate Diagnostics Inc (AXDX) reports significant improvements in gross margin and strategic progress in clinical trials and product approvals.

GuruFocus.com 2 months ago

AXDX
+0.90%
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -25.53% and 0.83%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

AXDX
+0.90%
Accelerate Diagnostics: Q3 Earnings Snapshot

TUCSON, Ariz. AP) — Accelerate Diagnostics Inc. AXDX) on Thursday reported a third-quarter loss of $14.6 million, after reporting a profit in the same period a year earlier.

Associated Press Finance 2 months ago

AXDX
+0.90%
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2024.

PR Newswire 2 months ago

AXDX
+0.90%
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced that management will host a conference call Thursday, November 7, 2024, at 4:30 p.m. Eastern Time to review 2024 third quarter results.

PR Newswire 2 months ago

AXDX
+0.90%
Accelerate Diagnostics Inc (AXDX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...

Despite a net loss, Accelerate Diagnostics Inc (AXDX) makes significant strides with its WAVE platform and secures funding through 2025.

GuruFocus.com 3 months ago

AXDX
+0.90%
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System

AXDX's Arc system gains FDA clearance, automating blood culture prep for faster microbial ID, improved sepsis outcomes and reduced hospital costs.

Zacks 3 months ago

AXDX
+0.90%
BRKR
FDA approves Accelerate Arc system to identify microbial infections

The system streamlines the preparation of positive blood culture samples in clinical labs, accelerating microbial identification.

Medical Device Network 3 months ago

AXDX
+0.90%
BRKR
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System

Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the Accelerate Arc system and BC kit, an innovative, automated positive blood culture sample preparation platform, for use with Bruker's MALDI Biotyper® CA System (MBT-CA System) and MBT-CA Sepsityper® software extension.

PR Newswire 3 months ago

AXDX
+0.90%
Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial

Accelerate Diagnostics (AXDX) is confident about WAVE product design and the system's capabilities after the successful completion of the pre-clinical trial.

Zacks 5 months ago

AXDX
+0.90%
DGX
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 9.09% and 0.47%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 5 months ago

AXDX
+0.90%
Accelerate Diagnostics: Q2 Earnings Snapshot

TUCSON, Ariz. AP) — Accelerate Diagnostics Inc. AXDX) on Thursday reported a loss of $11.6 million in its second quarter.

Associated Press Finance 5 months ago

AXDX
+0.90%
Accelerate Diagnostics Reports Second Quarter 2024 Financial Results

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2024.

PR Newswire 5 months ago

AXDX
+0.90%
Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the successful completion of its WAVE pre-clinical trial. The Accelerate WAVE system is designed to deliver rapid antimicrobial susceptibility testing ("AST") directly from positive blood culture ("PBC") bottles and bacterial isolated colonies ("Isolates") to report accurate results within 4.5 hours, on average.

PR Newswire 5 months ago

AXDX
+0.90%
Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced that management will host a conference call today, Thursday, August 8, 2024, at 4:30 p.m. Eastern Time to review 2024 second quarter results.

PR Newswire 5 months ago

AXDX
+0.90%
Ekso Bionics (EKSO) Reports Q2 Loss, Lags Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -18.18% and 7.30%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 5 months ago

AXDX
+0.90%
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript May 8, 2024 Accelerate Diagnostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Accelerate Diagnostics Incorporated. First Quarter 2024 Results Conference Call. All participants […]

Insider Monkey 8 months ago

AXDX
+0.90%
Q1 2024 Accelerate Diagnostics Inc Earnings Call

Q1 2024 Accelerate Diagnostics Inc Earnings Call

Thomson Reuters StreetEvents 8 months ago

AXDX
+0.90%

Performance Overview

Return	AXDX	S&P 500
YTD	-2.61%	+0.51%
1-Year	-69.73%	+24.11%
3-Year	-97.27%	+27.33%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Accelerate Diagnostics, Inc. (AXDX)

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results

Q3 2024 Accelerate Diagnostics Inc Earnings Call

Accelerate Diagnostics Inc (AXDX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

Accelerate Diagnostics: Q3 Earnings Snapshot

Accelerate Diagnostics Reports Third Quarter 2024 Financial Results

Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results

Accelerate Diagnostics Inc (AXDX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...

Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System

FDA approves Accelerate Arc system to identify microbial infections

Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System

Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial

Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

Accelerate Diagnostics: Q2 Earnings Snapshot

Accelerate Diagnostics Reports Second Quarter 2024 Financial Results

Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial

Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results

Ekso Bionics (EKSO) Reports Q2 Loss, Lags Revenue Estimates

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript

Q1 2024 Accelerate Diagnostics Inc Earnings Call

Performance Overview